These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 2885642)

  • 41. [A trial to produce an inactivated Lassa fever vaccine].
    Krasnianskiĭ VP; Potryvaeva NV; Borisevich IV; Gradoboev VN; Pashanina TP; Pshenichnov VA
    Vopr Virusol; 1993; 38(6):276-9. PubMed ID: 8303891
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Advanced vaccine candidates for Lassa fever.
    Lukashevich IS
    Viruses; 2012 Oct; 4(11):2514-57. PubMed ID: 23202493
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Evaluating the immunogenicity and protective efficacy of a DNA vaccine encoding Lassa virus nucleoprotein.
    Rodriguez-Carreno MP; Nelson MS; Botten J; Smith-Nixon K; Buchmeier MJ; Whitton JL
    Virology; 2005 Apr; 335(1):87-98. PubMed ID: 15823608
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [An evaluation of the possibility of obtaining an inactivated vaccine against Lassa fever].
    Krasnianskiĭ VP; Potryvaeva NV; Borisevich IV; Gradoboev VN; Pashanina TP; Pshenichnov VA
    Zh Mikrobiol Epidemiol Immunobiol; 1994; (6):74-5. PubMed ID: 7879553
    [No Abstract]   [Full Text] [Related]  

  • 45. Progress in recombinant DNA-derived vaccines for Lassa virus and filoviruses.
    Grant-Klein RJ; Altamura LA; Schmaljohn CS
    Virus Res; 2011 Dec; 162(1-2):148-61. PubMed ID: 21925552
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Lassa fever virus in Senegal.
    Saluzzo JF; Adam F; McCormick JB; Digoutte JP
    J Infect Dis; 1988 Mar; 157(3):605. PubMed ID: 3343533
    [No Abstract]   [Full Text] [Related]  

  • 47. Identification of messenger RNA for nucleocapsid protein of Lassa virus in infected cells.
    Lukashevich IS; Stelmakh TA; Stchesljenok EP; Shkolina TV
    Intervirology; 1988; 29(2):120-4. PubMed ID: 2900821
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Characteristics of the immune response in mice immunized with the inactivated Lassa virus].
    Ignat'ev GM; Golubev VP; Godneva AT; Petkevich AS; Torop AV
    Vopr Virusol; 1989; 34(2):213-6. PubMed ID: 2474905
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A live attenuated vaccine for Lassa fever made by reassortment of Lassa and Mopeia viruses.
    Lukashevich IS; Patterson J; Carrion R; Moshkoff D; Ticer A; Zapata J; Brasky K; Geiger R; Hubbard GB; Bryant J; Salvato MS
    J Virol; 2005 Nov; 79(22):13934-42. PubMed ID: 16254329
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The search for animal models for Lassa fever vaccine development.
    Lukashevich IS
    Expert Rev Vaccines; 2013 Jan; 12(1):71-86. PubMed ID: 23256740
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Lassa Virus Vaccine Candidate ML29 Generates Truncated Viral RNAs Which Contribute to Interfering Activity and Attenuation.
    Johnson DM; Cubitt B; Pfeffer TL; de la Torre JC; Lukashevich IS
    Viruses; 2021 Jan; 13(2):. PubMed ID: 33573250
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Development and study of properties of immunoglobulins against Lassa fever].
    Krasnianskiĭ VP; Gradoboev VN; Borisevich IV; Potryvaeva NV; Lebedinskaia EV; Chernikova NK; Timan'kova GD
    Vopr Virusol; 1997; 42(4):168-71. PubMed ID: 9304297
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A DNA vaccine delivered by dermal electroporation fully protects cynomolgus macaques against Lassa fever.
    Cashman KA; Wilkinson ER; Shaia CI; Facemire PR; Bell TM; Bearss JJ; Shamblin JD; Wollen SE; Broderick KE; Sardesai NY; Schmaljohn CS
    Hum Vaccin Immunother; 2017 Dec; 13(12):2902-2911. PubMed ID: 29045192
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Antibodies to Lassa virus Z protein and nucleoprotein co-occur in human sera from Lassa fever endemic regions.
    Günther S; Kühle O; Rehder D; Odaibo GN; Olaleye DO; Emmerich P; ter Meulen J; Schmitz H
    Med Microbiol Immunol; 2001 Sep; 189(4):225-9. PubMed ID: 11599793
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Quadrivalent VesiculoVax vaccine protects nonhuman primates from viral-induced hemorrhagic fever and death.
    Cross RW; Xu R; Matassov D; Hamm S; Latham TE; Gerardi CS; Nowak RM; Geisbert JB; Ota-Setlik A; Agans KN; Luckay A; Witko SE; Soukieh L; Deer DJ; Mire CE; Feldmann H; Happi C; Fenton KA; Eldridge JH; Geisbert TW
    J Clin Invest; 2020 Jan; 130(1):539-551. PubMed ID: 31820871
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Genetic variation in vitro and in vivo of an attenuated Lassa vaccine candidate.
    Zapata JC; Goicochea M; Nadai Y; Eyzaguirre LM; Carr JK; Tallon LJ; Sadzewicz L; Myers G; Fraser CM; Su Q; Djavani M; Lukashevich IS; Salvato MS
    J Virol; 2014 Mar; 88(6):3058-66. PubMed ID: 24335292
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Detection of Lassa virus antinucleoprotein immunoglobulin G (IgG) and IgM antibodies by a simple recombinant immunoblot assay for field use.
    Ter Meulen J; Koulemou K; Wittekindt T; Windisch K; Strigl S; Conde S; Schmitz H
    J Clin Microbiol; 1998 Nov; 36(11):3143-8. PubMed ID: 9774554
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Identification of protective Lassa virus epitopes that are restricted by HLA-A2.
    Botten J; Alexander J; Pasquetto V; Sidney J; Barrowman P; Ting J; Peters B; Southwood S; Stewart B; Rodriguez-Carreno MP; Mothe B; Whitton JL; Sette A; Buchmeier MJ
    J Virol; 2006 Sep; 80(17):8351-61. PubMed ID: 16912286
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Passive antibody therapy of Lassa fever in cynomolgus monkeys: importance of neutralizing antibody and Lassa virus strain.
    Jahrling PB; Peters CJ
    Infect Immun; 1984 May; 44(2):528-33. PubMed ID: 6715049
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Vaccine platforms for the prevention of Lassa fever.
    Purushotham J; Lambe T; Gilbert SC
    Immunol Lett; 2019 Nov; 215():1-11. PubMed ID: 31026485
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.